|
Vertex Pharmaceuticals Inc - Company Profile Snapshot
| Company Profile: |
Vertex Pharmaceuticals Inc |
| Ticker: |
VRTX |
| Exchanges: |
NAS |
| 2008 Sales: |
175,500,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
UNITED STATES |
| Employees: |
1333 |
Business Description
Vertex Pharmaceuticals Inc. The Group's principal activity is to discover, develop and market small molecule drugs for the treatment of serious diseases. These drugs used for the treatment of diseases like HIV infection, chronic hepatitis C virus infection, inflammatory and autoimmune disorders, cancer, bacterial infection, pain and other neurological diseases, independently and with collaborators. The Group's telaprevir drug candidate, is an oral hepatitis C protease inhibitor and new class of antiviral treatments in clinical development that target hepatitis C virus or HCV, infection, a life-threatening disease.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
